
Mark L. Berch
Examiner (ID: 99)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1202, 1624, 1622, 1802, 2899, 1614, 1611 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 537128
[patent_doc_number] => 07176312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-13
[patent_title] => 'Kinase inhibitor scaffolds and methods for their preparation'
[patent_app_type] => utility
[patent_app_number] => 10/270030
[patent_app_country] => US
[patent_app_date] => 2002-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16325
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/176/07176312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10270030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/270030 | Kinase inhibitor scaffolds and methods for their preparation | Oct 11, 2002 | Issued |
Array
(
[id] => 963832
[patent_doc_number] => 06949644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-27
[patent_title] => 'Methods for the synthesis of substituted purines'
[patent_app_type] => utility
[patent_app_number] => 10/270031
[patent_app_country] => US
[patent_app_date] => 2002-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 15570
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10270031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/270031 | Methods for the synthesis of substituted purines | Oct 11, 2002 | Issued |
Array
(
[id] => 7034261
[patent_doc_number] => 20050032771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Process for the preparation of cefixime via alkyl-or aryl-sulfonates'
[patent_app_type] => utility
[patent_app_number] => 10/494700
[patent_app_country] => US
[patent_app_date] => 2002-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3321
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494700
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494700 | Process for the preparation of cefixime via alkyl-or aryl-sulfonates | Oct 10, 2002 | Abandoned |
Array
(
[id] => 7434940
[patent_doc_number] => 20040266750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Beta-lactamyl vasopressin v1aantagonists'
[patent_app_type] => new
[patent_app_number] => 10/492323
[patent_app_country] => US
[patent_app_date] => 2004-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31826
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492323
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492323 | β-Lactamyl vasopressin V1a Antagonists | Oct 10, 2002 | Issued |
Array
(
[id] => 6730736
[patent_doc_number] => 20030186926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => '2-propynyl adenosine analogs having A2A agonist activity and compositions thereof'
[patent_app_type] => new
[patent_app_number] => 10/263379
[patent_app_country] => US
[patent_app_date] => 2002-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 27504
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263379 | 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof | Sep 30, 2002 | Issued |
Array
(
[id] => 6725753
[patent_doc_number] => 20030208065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Process for purification of a cephalosporin derivative'
[patent_app_type] => new
[patent_app_number] => 10/261748
[patent_app_country] => US
[patent_app_date] => 2002-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4538
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20030208065.pdf
[firstpage_image] =>[orig_patent_app_number] => 10261748
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/261748 | Process for purification of a cephalosporin derivative | Sep 29, 2002 | Issued |
Array
(
[id] => 6706457
[patent_doc_number] => 20030153191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Novel crystal form of pyrrolidylthiocarbapenem derivative'
[patent_app_type] => new
[patent_app_number] => 10/240465
[patent_app_country] => US
[patent_app_date] => 2002-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4842
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153191.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240465
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240465 | Novel crystal form of pyrrolidylthiocarbapenem derivative | Sep 29, 2002 | Abandoned |
| 10/089951 | Amine derivatives | Sep 26, 2002 | Abandoned |
Array
(
[id] => 1113381
[patent_doc_number] => 06803460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-12
[patent_title] => 'Process for the fermentative production of cephalosporin'
[patent_app_type] => B2
[patent_app_number] => 10/254622
[patent_app_country] => US
[patent_app_date] => 2002-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8265
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/803/06803460.pdf
[firstpage_image] =>[orig_patent_app_number] => 10254622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/254622 | Process for the fermentative production of cephalosporin | Sep 23, 2002 | Issued |
Array
(
[id] => 6669681
[patent_doc_number] => 20030114665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates'
[patent_app_type] => new
[patent_app_number] => 10/252813
[patent_app_country] => US
[patent_app_date] => 2002-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14897
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252813
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252813 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | Sep 22, 2002 | Abandoned |
Array
(
[id] => 6653189
[patent_doc_number] => 20030105324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Camptothecin analogs and methods of preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/251153
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17050
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251153 | Camptothecin analogs and methods of preparation thereof | Sep 19, 2002 | Abandoned |
Array
(
[id] => 7410226
[patent_doc_number] => 20040176351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Process for making carbapenem compounds'
[patent_app_type] => new
[patent_app_number] => 10/485134
[patent_app_country] => US
[patent_app_date] => 2004-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6301
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485134
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485134 | Process for making carbapenem compounds | Sep 19, 2002 | Issued |
Array
(
[id] => 284161
[patent_doc_number] => RE040794
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2009-06-23
[patent_title] => 'Crystalline forms of carbapenem antibiotics and methods of preparation'
[patent_app_type] => reissue
[patent_app_number] => 11/999720
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2579
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/040/RE040794.pdf
[firstpage_image] =>[orig_patent_app_number] => 11999720
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/999720 | Crystalline forms of carbapenem antibiotics and methods of preparation | Sep 19, 2002 | Issued |
Array
(
[id] => 6745699
[patent_doc_number] => 20030022882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Process for the production of clavulanic acid salts'
[patent_app_type] => new
[patent_app_number] => 10/251948
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1963
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022882.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251948 | Process for the production of clavulanic acid salts | Sep 19, 2002 | Abandoned |
Array
(
[id] => 7276366
[patent_doc_number] => 20040235817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Crystalline forms of ertapenem sodium'
[patent_app_type] => new
[patent_app_number] => 10/485319
[patent_app_country] => US
[patent_app_date] => 2004-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2475
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485319 | Crystalline forms of carbapenem antibiotics and methods of preparation | Sep 19, 2002 | Issued |
Array
(
[id] => 990922
[patent_doc_number] => 06919449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-19
[patent_title] => 'Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds'
[patent_app_type] => utility
[patent_app_number] => 10/245490
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4219
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919449.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245490
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245490 | Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds | Sep 17, 2002 | Issued |
Array
(
[id] => 6751188
[patent_doc_number] => 20030045709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Crystalline forms of carbapenem intermediates'
[patent_app_type] => new
[patent_app_number] => 10/242222
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1644
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10242222
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/242222 | Crystalline forms of carbapenem intermediates | Sep 11, 2002 | Abandoned |
Array
(
[id] => 1063312
[patent_doc_number] => 06849736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-01
[patent_title] => 'Crystalline forms of valacyclovir hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 10/236729
[patent_app_country] => US
[patent_app_date] => 2002-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11200
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849736.pdf
[firstpage_image] =>[orig_patent_app_number] => 10236729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/236729 | Crystalline forms of valacyclovir hydrochloride | Sep 5, 2002 | Issued |
Array
(
[id] => 1105306
[patent_doc_number] => 06812232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-02
[patent_title] => 'Heterocycle substituted purine derivatives as potent antiproliferative agents'
[patent_app_type] => B2
[patent_app_number] => 10/237530
[patent_app_country] => US
[patent_app_date] => 2002-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57112
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 534
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/812/06812232.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237530 | Heterocycle substituted purine derivatives as potent antiproliferative agents | Sep 5, 2002 | Issued |
Array
(
[id] => 5852033
[patent_doc_number] => 20060235224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Process for preparing 2.6-dichloropurine'
[patent_app_type] => utility
[patent_app_number] => 10/488853
[patent_app_country] => US
[patent_app_date] => 2002-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1110
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235224.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488853 | Process for preparing 2.6-dichloropurine | Sep 2, 2002 | Abandoned |